DCGI approves two COVID-19 vaccines: Here is who said what

New Delhi: The Drugs Controller General of India has approved both Serum Institute of India and Bharat Biotech’s COVID-19 vaccines for restricted emergency use in the country.

DCGI said that the interim data suggests that the vaccine (Cadila Healthcare’s vaccine) is safe and immunogenic with three doses when administered intradermally.

India closer to Covid-19 vaccine, Drug Controller hints for approval

Here is who said what:

 

The post DCGI approves two COVID-19 vaccines: Here is who said what appeared first on NewsroomPost.



from NewsroomPost https://ift.tt/388HJeb
https://ift.tt/3hAdVdm

Comments